Productos farmacéuticos y dispositivos médicos
Featured news
Other news
Payer involvement is important for a successful EU HTA framework!
The International Association of Mutual Benefit Societies (AIM) welcom...
08.07.2021- Read more
AIM successfully launches its Calculator for Fair Medicines Prices in Europe
The International Association of Mutual Benefit Societies (AIM) has la...
11.06.2021- Read more
Joint Statement – Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy
Ahead of Friday 18 September's webinar the EU Vaccine Strategy, a numb...
21.09.2020- Read more
AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union
AIM, the International Association of Mutual Benefit Societies, has ar...
03.07.2020- Read more
EU Collaboration on Vaccination
The current outbreak of COVID-19, its crippling effects on European ec...
22.04.2020- Read more
European patients need fair medicines prices
The press regularly announces the discovery of a new drug or the purch...
04.12.2019- Read more
Medical Devices: Time to implement Regulations and increase Transparency
AIM, together with the European Association of Hospital Pharmacists (E...
26.02.2019- Read more
AIM director’s interview on HTA
AIM’s perspectives on Health Technology Assessments – An EU-wide a...
12.02.2018- Download
AIM publishes position on TFAs
AIM answered the open public consultation on the initiative to limit i...
22.01.2018- Read more